Press release
Prescription Dermatological Drugs Market Anticipated To Witness Robust Growth, Surpassing 52.26 Billion By 2029
Prescription Dermatological Drugs
What Is the Current Prescription Dermatological Drugs Market Size and Its Estimated Growth Rate?
The market size for prescription dermatological drugs has seen a significant upsurge in the past few years. The value of the market is expected to rise from $37.77 billion in 2024 to $40.38 billion in 2025, indicating a compound annual growth rate (CAGR) of 6.9%. Factors contributing to the historic growth include an increase in skin disorder cases, heightened skin health awareness, expansion of dermatology clinics, a growing elderly population, a boost in TH*Care expenditure, and increased investments in research and development.
The market size for prescription dermatological drugs is predicted to experience significant growth in the coming years, with an expected value of $52.27 billion in 2029 and a compound annual growth rate (CAGR) of 6.7%. Factors contributing to this growth during the predicted period include an increase in skin disorders, heightened awareness about skin health, wider acceptance of telemedicine for dermatological consultations, a growing focus on skin care aesthetics, improved insurance coverage for skin treatments, and a rising demand for customised medicine and precision dermatology. The future trends include development of targeted biologic therapies, the use of gene editing for treating skin conditions, advancements in medicine delivery systems, the use of personalised treatments through genetic profiling, enhanced absorption of topical medications, and the utilization of artificial intelligence for refining drug formulations and treatment plans.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21262
How Are Emerging Segments Shaping the Prescription Dermatological Drugs Market Landscape?
The prescription dermatological drugs market covered in this report is segmented -
1) By Drug Class: Corticosteroids, Retinoids, Calcineurin Inhibitors, Antifungal Agents, Antibiotics, Other Drug Classes
2) By Indication: Acne, Psoriasis, Dermatitis, Fungal Skin Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Retinoids: Topical Retinoids, Oral Retinoids
3) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors, Oral Calcineurin Inhibitors
4) By Antifungal Agents: Topical Antifungals, Oral Antifungals
5) By Antibiotics: Topical Antibiotics, Oral Antibiotics
6) By Other Drug Classes: Immunosuppressants, Phototherapy Agents
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21262&type=smp
Which Growth Factors Are Influencing Prescription Dermatological Drugs Market Expansion?
The rise in dermatological conditions is anticipated to propel the prescription dermatological drugs market's expansion. These conditions, encompassing skin, hair, or nail disorders such as eczema, psoriasis, and acne, necessitate medical intervention for effective symptom management. The surge in dermatological conditions can be primarily attributed to increasing contact with environmental pollutants, shifts in lifestyle, and escalating stress levels. Prescription dermatological medications are crucial in tackling these conditions as they offer specialized treatments to lessen symptoms and enhance long-term skin health. For example, in a March 2022 study reported by Europe PubMed Central, a UK-based organization managed by EMBL's European Bioinformatics Institute for biomedical research work, nearly 43.35% of participants across 27 European countries, approximately equivalent to 185 million individuals, had at least one skin condition. The most commonly encountered conditions included fungal infections, atopic dermatitis, and acne. Hence, the escalating incidence of dermatological conditions is fueling the expansion of the prescription dermatological drugs market.
Who Are the Dominant Players Across Different Prescription Dermatological Drugs Market Segments?
Major companies operating in the prescription dermatological drugs market are Pfizer Inc., Johnson & Johnson, Merck KGaA, AbbVie Inc., Bayer AG, Novartis AG, GSK plc, Amgen Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Inc., Regeneron Pharmaceuticals Inc., Mylan NV, Sun Pharmaceutical Industries Ltd., Cipla Limited, Dr. Reddy's Laboratories Ltd., Zydus Cadila Health Care Limited, Leo Pharma A/S, Glenmark Pharmaceuticals Limited, Almirall S.A., DermBiont Inc.
What Trends Are Expected to Dominate the Prescription Dermatological Drugs Market in the Next 5 Years?
Leading entities in the prescription dermatological drug market are prioritizing the creation of groundbreaking treatments like prurigo nodularis with an aim to cater to unfulfilled medical requirements and provide more efficacious remedies for individuals afflicted by persistent and problematic skin ailments. Characterized by agonizingly prickly, inflated, and hard nodules or lumps on the skin, prurigo nodularis is a long-term skin disorder. In a noteworthy development in September 2022, a partnership was forged between Regeneron Pharmaceuticals Inc., a US-origin biotechnology firm, and Sanofi S.A., a pharmaceutical organization based in France. This partnership led to the approval from the U.S. Food and Drug Administration (FDA) for Dupixent (dupilumab), making it the first and unique FDA-sanctioned treatment for prurigo nodularis. This approval was accorded on the basis of clinical tests that showed considerable enhancements in the intensity of itching and skin lesions in patients who received Dupixent treatment, as opposed to those given a placebo.
Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/prescription-dermatological-drugs-global-market-report
Which Geographic Regions Are Expected to Dominate the Prescription Dermatological Drugs Market in the Coming Years?
North America was the largest region in the prescription dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription dermatological drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Prescription Dermatological Drugs Market?
2. What is the CAGR expected in the Prescription Dermatological Drugs Market?
3. What Are the Key Innovations Transforming the Prescription Dermatological Drugs Industry?
4. Which Region Is Leading the Prescription Dermatological Drugs Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Prescription Dermatological Drugs Market Anticipated To Witness Robust Growth, Surpassing 52.26 Billion By 2029 here
News-ID: 4069364 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Drug
Injectable Drug Delivery Market Injectable Drug Delivery Market
Leading market research firm SkyQuest Technology Group recently released a study titled ' Injectable Drug Delivery Market Global Size, Share, Growth, Industry Trends, Opportunity and Forecast 2024-2031,' This study Injectable Drug Delivery report offers a thorough analysis of the market, as well as competitor and geographical analysis and a focus on the most recent technological developments. The research study on the Injectable Drug Delivery Market extensively demonstrates existing and upcoming…
Global Advanced Drug Delivery Systems Market Size - By Product Type(Oral Drug De …
Market Overview and Report Coverage
Advanced Drug Delivery Systems (ADDS) refer to innovative technologies designed to improve the administration and efficacy of therapeutics, enhancing the way medications are delivered to targeted areas within the body. These systems aim to optimize treatment outcomes by increasing the bioavailability, reducing side effects, and facilitating controlled drug release. Employing methods such as nanoparticles, liposomes, and implantable pumps, ADDS are revolutionizing personalized medicine and expanding therapeutic…
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Pric …
Global Cancer Antibody Drug Conjugate Market Size, Drug Sales, Drug Dosage, Price, and Clinical Trials Outlook 2029 Report Highlights:
* Global Antibody Drug Conjugates Market Opportunity: > 40 Billion By 2029
* Global and Regional Antibody Drug Conjugate Market Insight
* Approved Drugs Sales Insight Global and Regional, Yearly and Quarterly, 2019 -2023
* Approved Antibody Drug Conjugates - Availability, Dosage and Price Insight
* Insight On Antibody Drug Conjugates In Clinical Trials: > 550…
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
